148 related articles for article (PubMed ID: 20128919)
1. Loratadine dysregulates cell cycle progression and enhances the effect of radiation in human tumor cell lines.
Soule BP; Simone NL; DeGraff WG; Choudhuri R; Cook JA; Mitchell JB
Radiat Oncol; 2010 Feb; 5():8. PubMed ID: 20128919
[TBL] [Abstract][Full Text] [Related]
2. Checkpoint kinase 1-mediated phosphorylation of Cdc25C and bad proteins are involved in antitumor effects of loratadine-induced G2/M phase cell-cycle arrest and apoptosis.
Chen JS; Lin SY; Tso WL; Yeh GC; Lee WS; Tseng H; Chen LC; Ho YS
Mol Carcinog; 2006 Jul; 45(7):461-78. PubMed ID: 16649252
[TBL] [Abstract][Full Text] [Related]
3. [Potentiation of radiosensitivity by staurosporine associated with abrogation of G2 phase arrest].
Sun XC; Wang JJ; Zhen YS; Shao RG
Yao Xue Xue Bao; 2002 Jun; 37(6):419-23. PubMed ID: 12579796
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo radiation sensitization of human tumor cells by a novel checkpoint kinase inhibitor, AZD7762.
Mitchell JB; Choudhuri R; Fabre K; Sowers AL; Citrin D; Zabludoff SD; Cook JA
Clin Cancer Res; 2010 Apr; 16(7):2076-84. PubMed ID: 20233881
[TBL] [Abstract][Full Text] [Related]
5. In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations.
Raju U; Nakata E; Yang P; Newman RA; Ang KK; Milas L
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):886-94. PubMed ID: 12377342
[TBL] [Abstract][Full Text] [Related]
6. Selective radiosensitization of human cervical cancer cells and normal cells by artemisinin through the abrogation of radiation-induced G2 block.
Gong XM; Zhang Q; Torossian A; Cao JP; Fu S
Int J Gynecol Cancer; 2012 Jun; 22(5):718-24. PubMed ID: 22552829
[TBL] [Abstract][Full Text] [Related]
7. Icotinib hydrochloride enhances the effect of radiotherapy by affecting DNA repair in colorectal cancer cells.
Ma H; Bi J; Liu T; Ke Y; Zhang S; Zhang T
Oncol Rep; 2015 Mar; 33(3):1161-70. PubMed ID: 25572529
[TBL] [Abstract][Full Text] [Related]
8. Caffeine-increased radiosensitivity is not dependent on a loss of G2/M arrest or apoptosis in bladder cancer cell lines.
Ribeiro JC; Barnetson AR; Jackson P; Ow K; Links M; Russell PJ
Int J Radiat Biol; 1999 Apr; 75(4):481-92. PubMed ID: 10331854
[TBL] [Abstract][Full Text] [Related]
9. Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells.
Raju U; Nakata E; Mason KA; Ang KK; Milas L
Cancer Res; 2003 Jun; 63(12):3263-7. PubMed ID: 12810657
[TBL] [Abstract][Full Text] [Related]
10. Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damage.
Ha K; Fiskus W; Rao R; Balusu R; Venkannagari S; Nalabothula NR; Bhalla KN
Mol Cancer Ther; 2011 Jul; 10(7):1194-206. PubMed ID: 21566061
[TBL] [Abstract][Full Text] [Related]
11. DAP3-mediated cell cycle regulation and its association with radioresistance in human lung adenocarcinoma cell lines.
Sato Y; Yoshino H; Sato K; Kashiwakura I; Tsuruga E
J Radiat Res; 2023 May; 64(3):520-529. PubMed ID: 37023702
[TBL] [Abstract][Full Text] [Related]
12. Targeted radiosensitization by the Chk1 inhibitor SAR-020106.
Borst GR; McLaughlin M; Kyula JN; Neijenhuis S; Khan A; Good J; Zaidi S; Powell NG; Meier P; Collins I; Garrett MD; Verheij M; Harrington KJ
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1110-8. PubMed ID: 22981708
[TBL] [Abstract][Full Text] [Related]
13. G2-checkpoint targeting and radiosensitization of HPV/p16-positive HNSCC cells through the inhibition of Chk1 and Wee1.
Busch CJ; Kröger MS; Jensen J; Kriegs M; Gatzemeier F; Petersen C; Münscher A; Rothkamm K; Rieckmann T
Radiother Oncol; 2017 Feb; 122(2):260-266. PubMed ID: 27939202
[TBL] [Abstract][Full Text] [Related]
14. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.
Wang Q; Fan S; Eastman A; Worland PJ; Sausville EA; O'Connor PM
J Natl Cancer Inst; 1996 Jul; 88(14):956-65. PubMed ID: 8667426
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the R2 subunit of ribonucleotide reductase in human nasopharyngeal cancer cells reduces radiosensitivity.
Kuo ML; Hwang HS; Sosnay PR; Kunugi KA; Kinsella TJ
Cancer J; 2003; 9(4):277-85. PubMed ID: 12967138
[TBL] [Abstract][Full Text] [Related]
16. The Chk1-Cdc25C regulation is involved in sensitizing A253 cells to a novel topoisomerase I inhibitor BNP1350 by bax gene transfer.
Yin M; Hapke G; Guo B; Azrak RG; Frank C; Rustum YM
Oncogene; 2001 Aug; 20(38):5249-57. PubMed ID: 11536038
[TBL] [Abstract][Full Text] [Related]
17. Radiation-induced phosphorylation of Chk1 at S345 is associated with p53-dependent cell cycle arrest pathways.
Tian H; Faje AT; Lee SL; Jorgensen TJ
Neoplasia; 2002; 4(2):171-80. PubMed ID: 11896572
[TBL] [Abstract][Full Text] [Related]
18. Radiosensitization by Chir-124, a selective CHK1 inhibitor: effects of p53 and cell cycle checkpoints.
Tao Y; Leteur C; Yang C; Zhang P; Castedo M; Pierré A; Golsteyn RM; Bourhis J; Kroemer G; Deutsch E
Cell Cycle; 2009 Apr; 8(8):1196-205. PubMed ID: 19305158
[TBL] [Abstract][Full Text] [Related]
19. An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage.
Jackson JR; Gilmartin A; Imburgia C; Winkler JD; Marshall LA; Roshak A
Cancer Res; 2000 Feb; 60(3):566-72. PubMed ID: 10676638
[TBL] [Abstract][Full Text] [Related]
20. A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation.
Xiao Z; Xue J; Sowin TJ; Rosenberg SH; Zhang H
Oncogene; 2005 Feb; 24(8):1403-11. PubMed ID: 15608676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
